Page last updated: 2024-10-26

dilazep and Extravascular Hemolysis

dilazep has been researched along with Extravascular Hemolysis in 1 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, A1
Hayase, N1
Hashizume, H1
Abiko, Y1

Other Studies

1 other study available for dilazep and Extravascular Hemolysis

ArticleYear
Protective effects of dilazep and its derivative K-7259 on the haemolysis induced by amphiphiles in rat erythrocytes.
    The Journal of pharmacy and pharmacology, 1997, Volume: 49, Issue:8

    Topics: Animals; Dilazep; Erythrocytes; Hemolysis; Hypotonic Solutions; Lysophosphatidylcholines; Male; Mice

1997